Utility of Integrated Analysis of Pharmacogenomics and Pharmacometabolomics in Early Phase Clinical Trial: A Case Study of a New Molecular Entity

Utility of Integrated Analysis of Pharmacogenomics and Pharmacometabolomics in Early Phase Clinical Trial: A Case Study of a New Molecular Entity

In this report, we present a case study of how pharmacogenomics and pharmacometabolomics can be useful to characterize safety and pharmacokinetic profiles in early phase new drug development clinical trials. During conducting a first-in-human trial for a new molecular entity, we were able to determi...

Full description

Saved in:
Bibliographic Details
Main Authors: Jaeseong Oh, Sojeong Yi, Namyi Gu, Dongseong Shin, Kyung-Sang Yu, Seo Hyun Yoon, Joo-Youn Cho, In-Jin Jang
Format: Article
Language:English
Published: BioMed Central 2018-09-01
Series:Genomics & Informatics
Subjects:
clinical trial
metabolomics
new drug development
pharmacogenomics
Online Access:http://genominfo.org/upload/pdf/gi-2018-16-3-52.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

http://genominfo.org/upload/pdf/gi-2018-16-3-52.pdf

Similar Items